VisionCare Ophthalmic Technologies

Bookmark

Add to MyYahoo RSS

VisionCare Ophthalmic Technologies News

News on VisionCare Ophthalmic Technologies (Ticker: JNJ) continually updated from thousands of sources around the net.

2 hrs ago | Seeking Alpha

My Top Company For Income And Capital Gains

Once again, Johnson & Johnson has come through for investors. The company just reported a very solid first-quarter earnings report.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups, Johnson Controls

8 hrs ago | GuruFocus.com

Investor Steven Romick's Top 5 Increases of First Quarter

FPA Crescent Fund's Steven Romick in the first quarter preferred to have cash ready to put to work in case volatility hit the markets, rather than buy new stocks.

Comment?

Related Topix: Financial Markets, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups

12 hrs ago | JD Supra

Dallas Woman Awarded $1.2 Million, Mesh Called Defectively Designed

For the first time, a Texas jury has decided the pelvic mesh made by healthcare giant Johnson & Johnson was defectively designed .

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Scios, OrthoClinical Diagnostics, Medical Equipment

Wed Apr 16, 2014

Cosmetics Design

Johnson & Johnson drops PurTox

The company as a whole may have reported strong first quarter results, but Johnson & Johnson has ended efforts to rival Allergan's popular Botox anti-wrinkle treatment.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups, Johnson Controls

Denver Post

Corporate earnings: Coca-Cola, Intel, Yahoo, Johnson & Johnson

Coca-Cola. The world's biggest beverage maker said Tuesday that the amount of soda it sold globally fell for first time in 15 years.

Comment?

Related Topix: Johnson & Johnson, Beverages, Biotech, Coca-Cola Bottling Co., Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, CocaCola, Startups

Barron's

Target Price Increases Abound For J&J, But Stock Slips

Johnson & Johnson was giving up some of Tuesday's gains , although analysts were largely upbeat about the company's better-than-expected first-quarter earnings report, as evidenced by a flurry of target price increases.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Scios, OrthoClinical Diagnostics, Medical Equipment

ABC News

Smartphone Apps to Help Patients Take Their Meds

Several smartphone apps are available to help patients take their medications as prescribed.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups, Johnson Controls

AmericanBankingNews.com

Johnson & Johnson's Underperform Rating Reaffirmed at Credit Suisse

's stock had its "underperform" rating reiterated by equities research analysts at Credit Suisse in a research note issued to investors on Wednesday, Analyst Ratings News reports.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups, Johnson Controls

The New Zealand Herald

NZ shares joined global rally

New Zealand stocks joined a global rally as US company earnings growth lifted sentiment for equity markets.

Comment?

Related Topix: Financial Markets, Beverages, CocaCola, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups

Tue Apr 15, 2014

The Washington Post

J&J Pharmaceutical Success Drives Increase in 2014 Forecast

Johnson & Johnson, the world's biggest maker of health-care products, beat expectations and raised its 2014 forecast by focusing on new drugs and reducing its reliance on medical devices.

Comment?

Related Topix: Food, J and J Snack Foods, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, OrthoClinical Diagnostics, Medical Equipment

International Business Times

Global Markets Overview - 4/16/14

Global equities were mixed with US markets continuing their recovery, while European and emerging markets struggled.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups, Johnson Controls

The Wichita Eagle

J&J Q1 net up 8 percent on sales jump, lower costs

This Oct. 16 2012 photo shows Johnson and Johnson products, including Band Aid brand adhesive bandages, arranged for a photo in St. Petersburg, Fla.

Comment?

Related Topix: Food, J and J Snack Foods, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups

National Public Radio

Stocks End Higher, Extending A Modest Rally

Coca-Cola rose 4 percent after reporting higher sales of non-carbonated beverages.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups, Johnson Controls

Reuters

Us Stocks-Wall St dips as data, sinking momentum shares offset earnings

U.S. stocks dipped on Tuesday, as gains in Coca Cola and Johnson & Johnson after their quarterly earnings were offset by mixed economic data and a resumed slide in momentum shares.

Comment?

Related Topix: Financial Markets, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Beverages, CocaCola, Startups

The Hartford Courant

J&J beats forecasts as new drugs shine, shares jump

Johnson & Johnson reported quarterly earnings well above expectations, as strong sales of new drugs offset weak demand for consumer products and medical devices, and the company slightly raised its full-year profit view.

Comment?

Related Topix: Food, J and J Snack Foods, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Aria Systems, Startups

Pharmaceutical Processing

Johnson & Johnson Reports 2014 First-Quarter Results

Johnson & Johnson today announced sales of $18.1 billion for the first quarter of 2014, an increase of 3.5% as compared to the first quarter of 2013.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Conor Medsystems, Advanced Transit Dynamics

Mon Apr 14, 2014

TheStreet.com

Investing Ahead of Earnings: Johnson & Johnson and Coca Cola

NEW YORK -- It's still early in first-quarter earnings season, but it looks like companies that beat analysts' earnings estimates and spike higher are going to have a hard time holding on to those gains.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups, Johnson Controls

Business Journal

Scripps partners with Johnson & Johnson to spur new companies

The Scripps Research Institute has created a group to launch drug development companies based on the work of its scientists and its first collaborator is a big one: Johnson & Johnson Innovation.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups, Johnson Controls

Seeking Alpha

Buy Side Expecting More Earnings Growth From Johnson & Johnson

Johnson & Johnson is set to report FQ1 2014 earnings before the market opens on Tuesday, April 15th.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Aria Systems, Startups

Seeking Alpha

Why Johnson & Johnson Is Heading To $105

As long as Johnson & Johnson continues to rake in the profits, management should be left alone to execute its vision.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups, Johnson Controls

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••
•••